Meglumine in Developability Classification

WEBINAR

The Developability Classification System (DCS) is a modification of the well-established Biopharmaceutics Classification System (BCS) that focuses on the underlying reasons of poorly soluble compounds: Dissolution rate limitations (DCS IIa) and solubility limitations (DCS IIb). By using the DCS, we will focus on how Meglumine, an amino sugar, can support in solving challenges with poorly soluble compounds as well as API stability and how it can be used in advanced manufacturing technologies such as hot melt extrusion (HME).

In this webinar, you will learn:

• How the developability classification system emerged from the well-established biopharmaceutics classification system.
• How the DCS can distinguish between solubility and dissolution rate limited compounds.
• How Meglumine can help with improving solubility.
• Which other formulation challenges Meglumine can solve.